News Image

CORCEPT THERAPEUTICS INC (NASDAQ:CORT), a growth stock which is not overvalued.

By Mill Chart

Last update: Mar 24, 2025

Consider CORCEPT THERAPEUTICS INC (NASDAQ:CORT) as an affordable growth stock, identified by our stock screening tool. CORT is showcasing impressive growth figures and is well-positioned in terms of profitability, solvency, and liquidity. Moreover, it seems to be priced reasonably. Let's dive deeper into the analysis.


Affordable growth stocks image

Deciphering CORT's Growth Rating

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. CORT has earned a 9 for growth:

  • CORT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.53%, which is quite impressive.
  • CORT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.71% yearly.
  • CORT shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.93%.
  • Measured over the past years, CORT shows a quite strong growth in Revenue. The Revenue has been growing by 17.11% on average per year.
  • Based on estimates for the next years, CORT will show a very strong growth in Earnings Per Share. The EPS will grow by 54.51% on average per year.
  • The Revenue is expected to grow by 28.31% on average over the next years. This is a very strong growth
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Exploring CORT's Valuation

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. CORT has achieved a 6 out of 10:

  • Compared to the rest of the industry, the Price/Earnings ratio of CORT indicates a rather cheap valuation: CORT is cheaper than 80.73% of the companies listed in the same industry.
  • 78.13% of the companies in the same industry are more expensive than CORT, based on the Price/Forward Earnings ratio.
  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CORT indicates a somewhat cheap valuation: CORT is cheaper than 77.60% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CORT indicates a rather cheap valuation: CORT is cheaper than 82.29% of the companies listed in the same industry.
  • CORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CORT may justify a higher PE ratio.
  • CORT's earnings are expected to grow with 58.60% in the coming years. This may justify a more expensive valuation.

Health Analysis for CORT

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. CORT has earned a 8 out of 10:

  • An Altman-Z score of 25.79 indicates that CORT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 25.79, CORT belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
  • There is no outstanding debt for CORT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
  • A Current Ratio of 3.35 indicates that CORT has no problem at all paying its short term obligations.
  • A Quick Ratio of 3.26 indicates that CORT has no problem at all paying its short term obligations.

Evaluating Profitability: CORT

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. CORT has earned a 7 out of 10:

  • CORT's Return On Assets of 16.80% is amongst the best of the industry. CORT outperforms 97.92% of its industry peers.
  • With an excellent Return On Equity value of 20.78%, CORT belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 16.89%, CORT belongs to the top of the industry, outperforming 93.23% of the companies in the same industry.
  • CORT's Profit Margin of 20.92% is amongst the best of the industry. CORT outperforms 93.23% of its industry peers.
  • Looking at the Operating Margin, with a value of 20.29%, CORT belongs to the top of the industry, outperforming 86.46% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 98.39%, CORT belongs to the top of the industry, outperforming 97.92% of the companies in the same industry.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of CORT

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

CORCEPT THERAPEUTICS INC

NASDAQ:CORT (5/20/2025, 8:00:00 PM)

After market: 76.5 +0.28 (+0.37%)

76.22

+1.4 (+1.87%)



Find more stocks in the Stock Screener

CORT Latest News and Analysis

ChartMill News Image11 days ago - ChartmillLooking for growth without the hefty price tag? Consider CORCEPT THERAPEUTICS INC (NASDAQ:CORT).

Uncover the potential of CORCEPT THERAPEUTICS INC, a growth stock reasonably priced. NASDAQ:CORT is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.

ChartMill News Image13 days ago - ChartmillWill CORCEPT THERAPEUTICS INC (NASDAQ:CORT) breakout?

Exploring CORCEPT THERAPEUTICS INC's Technical Signals and Breakout Potential: Indications Suggest NASDAQ:CORT Could Be on the Verge of a Breakout.

ChartMill News Image15 days ago - ChartmillTop movers in Monday's after hours session

Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.

Mentions: NBIX MRIN OGEN AMRC ...

ChartMill News Image21 days ago - ChartmillCORCEPT THERAPEUTICS INC (NASDAQ:CORT), a strong growth stock, setting up for a breakout.

Based on a technical and fundamental analysis of NASDAQ:CORT we ask: Is CORCEPT THERAPEUTICS INC (NASDAQ:CORT) on the Verge of a Major Breakout as a Strong Growth Stock?

Follow ChartMill for more